Before Congress adjourned for Christmas, congressional leadership had set ambitious goals to counter the Chinese Communist Party. Speaker Mike Johnson (R-LA) and Chairman John Moolenaar (R-MI) identified three China policy priorities to address: closing trade loopholes that provided a highway for Uyghur slave labor-produced goods to America, cutting off U.S. cooperation with CCP-controlled biotechnology companies, and restricting American investments in companies domiciled in the People’s Republic of China directly or indirectly serving the People’s Liberation Army.
Their priorities were sound. Chinese companies like Temu and Shein are injecting slave-labor goods into the United States, circumventing U.S. law in the process. American companies were overly dependent on PRC biotechnology companies harvesting the DNA of Americans for nefarious purposes. Wall Street had invested in PLA-linked entities for decades and essentially underwritten Beijing’s military buildup.
